PURPOSE

Comparison

Comparison of biologic risk profile to MSKCC

STUDY

999 patients. Biologic risk profile vs. MSKCC weighted clin/path risk.

SUMMARY

  • ¬†Biologic Risk Profile reclassified 59% of the clin/path low risk group and 27% of the clin/path high risk group